Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development

Clinical and Vaccine Immunology

Volumn 16, Issue 11, 2009, Pages 1675-1686

  Donofrio, Gaetano ^a   Franceschi, Valentina ^a   Capocefalo, Antonio ^a   Taddei, Simone ^a   Sartori, Chiara ^a   Bonomini, Sabrina ^a   Cavirani, Sandro ^a   Cabassi, Clotilde S ^a   Flammini, Cesidio F ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; GLYCOPROTEIN D; GLYCOPROTEIN E2; GLYCOPROTEIN E2 PLUS GLYCOPROTEIN D; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BOVINE DIARRHEA VIRUS; BOVINE HERPES VIRUS; CELL SELECTION; CELL STRAIN HEK293; CONTROLLED STUDY; DIARRHEA; HERPES SIMPLEX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMORAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TARGET CELL;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, HETEROPHILE; DIARRHEA VIRUSES, BOVINE VIRAL; HERPESVIRUS 4, BOVINE; PROTEIN TRANSPORT; RABBITS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 70350714576     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00224-09     Document Type: Article

References (28)

1. Babiuk, L. A., S. van Drunen Littel-van den Hurk, and S. K. Tikoo. 1996. Immunology of bovine herpesvirus 1 infection. Vet. Microbiol. 53:31-42.
2. Collings, D. F., E. P. Gibbs, and L. P. Stafford. 1972. Concurrent respiratory and genital disease associated with infectious bovine rhinotracheitis-infectious pustular vulvo-vaginitis (IBR-IPV) virus in a dairy herd in the United Kingdom. Vet. Rec. 91:214-219.
3. Donofrio, G., A. Cavaggioni, M. Bondi, S. Cavirani, C. F. Flammini, and C. Mucignat-Caretta. 2006. Outcome of bovine herpesvirus 4 infection following direct viral injection in the lateral ventricle of the mouse brain. Microbes Infect. 8:898-904.
4. Donofrio, G., S. Cavirani, T. Simone, and V. L. van Santen. 2002. Potential of bovine herpesvirus 4 as a gene delivery vector. J. Virol. Methods 101:49-61. (Pubitemid 34159107)
5. Donofrio, G., S. Cavirani, A. Vanderplasschen, L. Gillet, and C. F. Flammini. 2006. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model. Clin. Vaccine Immunol. 13:1246-1254.
6. Donofrio, G., S. Herath, C. Sartori, S. Cavirani, C. F. Flammini, and I. M. Sheldon. 2007. Bovine herpesvirus 4 is tropic for bovine endometrial cells and modulates endocrine function. Reproduction 134:183-197. (Pubitemid 47244850)
7. Donofrio, G., L. Ravanetti, S. Cavirani, S. Herath, A. Capocefalo, and I. M. Sheldon. 2008. Bacterial infection of endometrial stromal cells influences bovine herpesvirus 4 immediate early gene activation: a new insight into bacterial and viral interaction for uterine disease. Reproduction 136:361-366.
8. Donofrio, G., C. Sartori, V. Franceschi, A. Capocefalo, S. Cavirani, S. Taddei, and C. F. Flammini. 2008. Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD. Vaccine 26:6031-6042.
9. Donofrio, G., C. Sartori, L. Ravanetti, S. Cavirani, L. Gillet, A. Vanderplasschen, S. Taddei, and C. F. Flammini. 2007. Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes. BMC Biotechnol. 7:68.
10. Egyed, L. 2000. Bovine herpesvirus type 4: a special herpesvirus. Acta Vet. Hung. 48:501-513.
11. Fulton, R. W., and L. J. Burge. 2000. Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Vaccine 19:264-274.
12. Fulton, R. W., A. W. Confer, L. J. Burge, L. J. Perino, J. M. d'Offay, M. E. Payton, and R. E. Mock. 1995. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140. Vaccine 13:725-733.
13. Fussenegger, M. 2001. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol. Prog. 17:1-51.
14. Grossberg, S. E., and Y. Kawade. 1997. The expression of potency of neutralizing antibodies for interferons and other cytokines. Biotherapy 10:93-98.
15. Jiang, Y., B. N. Jahagirdar, R. L. Reinhardt, R. E. Schwartz, C. D. Keene, X. R. Ortiz-Gonzalez, M. Reyes, T. Lenvik, T. Lund, M. Blackstad, J. Du, S. Aldrich, A. Lisberg, W. C. Low, D. A. Largaespada, and C. M. Verfaillie. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49. (Pubitemid 34742565)
16. Keil, G. M., A. Heinze, and B. Mächtig. 1990. Bovine herpesvirus 4 vector for life-virus vaccines? Zentralbl. Bakteriol. 272:375.
17. Lewis, P. J., S. van Drunen Littel-van den Hurk, and L. A. Babiuk. 1999. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J. Virol. 73:10214-10223.
18. Liang, R., J. V. van den Hurk, C. Zheng, H. Yu, R. A. Pontarollo, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2005. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. Vaccine. 23:5252-5262.
19. Lomonte, P., M. Bublot, P. P. Pastoret, and E. Thiry. 1992. Location and characterization of the bovine herpesvirus type 4 thymidine kinase gene; comparison with thymidine kinase genes of other herpesviruses. Arch. Virol. 127:327-337.
20. Mettenleiter, T. C. 1989. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry. Virology 171:623-625.
21. Osorio, F. A., D. L. Rock, and D. E. Reed. 1985. Studies on the pathogenesis of a bovine cytomegalo-like virus in an experimental host. J. Gen. Virol. 66:1941-1951.
22. Reddy, P. S., N. Idamakanti, C. Pyne, A. N. Zakhartchouk, D. L. Godson, Z. Papp, M. E. Baca-Estrada, L. A. Babiuk, G. K. Mutwiri, and S. K. Tikoo. 2000. The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle. Vet. Immunol. Immunopathol. 76:257-268.
23. Rusko, J., G. Van Slooten, and D. J. Adams. 1995. Caffeine-evoked, calcium-sensitive membrane currents in rabbit aortic endothelial cells. Br. J. Pharmacol. 115:133-141.
24. Tikoo, S. K., D. R. Fitzpatrick, L. A. Babiuk, and T. J. Zamb. 1990. Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J. Virol. 64:5132-5142. (Pubitemid 20329836)
25. Tikoo, S. K., M. D. Parker, J. V. van den Hurk, J. Kowalski, T. J. Zamb, and L. A. Babiuk. 1993. Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV. J. Virol. 67:726-733.
26. van Drunen Littel-van den Hurk, S., S. K. Tikoo, J. V. van den Hurk, L. A. Babiuk, and J. Van Donkersgoed. 1997. Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines. Vaccine 15:36-44.
27. van Drunen Littel-van den Hurk, S., J. V. van den Hurk, J. E. Gilchrist, V. Misra, and L. A. Babiuk. 1984. Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135:466-479.
28. Zaiss, A. K., M. J. Cotter, L. R. White, S. A. Clark, N. C. Wong, V. M. Holers, J. S. Bartlett, and D. A. Muruve. 2008. Complement is an essential component of the immune response to adeno-associated virus vectors. J. Virol. 82:2727-2740.